Abstract: The invention provides compositions comprising one or more bacterial strains for use in a method of reducing the level of Enterobacteriaceae in the gastrointestinal tract.
Abstract: Provided are compositions comprising a bacterial strain of the genus Blautia, for use in a method of increasing the microbiota diversity and/or stability of the microbiota of a subject.
Type:
Grant
Filed:
September 4, 2019
Date of Patent:
January 26, 2021
Assignee:
4D Pharma PLC
Inventors:
Ian Jeffery, Fergus Shanahan, Paul O'Toole, Alex Stevenson, Imke Mulder, Helene Savignac
Abstract: The invention provides compositions comprising one or more bacterial strains for use in a method of reducing the level of Enterobacteriaceae in the gastrointestinal tract.
Abstract: Provided are compositions comprising a bacterial strain of the genus Blautia, for use in a method of increasing the microbiota diversity and/or inducing stability of the microbiota of a subject.
Type:
Grant
Filed:
September 28, 2018
Date of Patent:
January 28, 2020
Assignee:
4D PHARMA PLC
Inventors:
Ian Jeffery, Fergus Shanahan, Paul O'Toole, Alex Stevenson, Imke Mulder, Helene Savignac
Abstract: Provided are compositions comprising a bacterial strain of the genus Blautia, for use in a method of increasing the microbiota diversity and/or inducing stability of the microbiota of a subject.
Type:
Grant
Filed:
June 28, 2018
Date of Patent:
November 26, 2019
Assignee:
4D PHARMA PLC
Inventors:
Ian Jeffery, Fergus Shanahan, Paul O'Toole, Alex Stevenson, Imke Mulder, Helene Savignac
Abstract: Provided are compositions comprising a bacterial strain of the genus Blautia, for use in a method of increasing the microbiota diversity and/or inducing stability of the microbiota of a subject.
Type:
Grant
Filed:
March 8, 2018
Date of Patent:
October 2, 2018
Assignee:
4D Pharma PLC
Inventors:
Ian Jeffery, Fergus Shanahan, Paul O'Toole, Alex Stevenson, Imke Mulder, Helene Savignac
Abstract: The invention provides compositions comprising one or more bacterial strains for use in a method of reducing the level of Enterobacteriaceae in the gastrointestinal tract.